MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    App-Based Speech Assessment Differentiates PD and PSP: A Feasibility Study in Italian Speakers

    T. Thies, S. Cuoco, M. Autuori, A. Sahay, J. Tröger, M. Picillo (Saarbrücken, Germany)

    Objective: To evaluate the feasibility of app-based speech assessment in Parkinson’s disease (PD) and progressive supranuclear palsy (PSP), and to explore group differences in speech…
  • 2026 International Congress

    Sublingual Apomorphine Tolerability in Clinical Practice: 18-months Post launch experience in Europe

    J. Kassubek, R. García-Ramos, M. F. Gago, H. Brigas, C. Deneck-Muhr, D. Lopes, C. Meneses, J. Holenz (Ulm, Germany)

    Objective: Describe the post-marketing safety profile of Sublingual apomorphine (SL-APO) in Europe during the first 18 months after launch. Background: SL-APO is an on-demand therapy…
  • 2026 International Congress

    Comparability of Smartphone App and Booth Recordings for Robust Acoustic Speech Monitoring in Parkinson’s Disease

    T. Thies, J. Strelow, D. Lopez, J. Tröger, I. Rubi-Fessen, M. Barbe, D. Mücke (Cologne, Germany)

    Objective: To assess the technical equivalence and scalability of remote app-based recordings against gold-standard laboratory conditions to identify reliable speech features suitable for longitudinal monitoring…
  • 2026 International Congress

    Effectiveness of Switching from Levodopa-Carbidopa Intestinal Gel to Levodopa-Carbidopa-Entacapone Intestinal Gel in Patients with Refractory Biphasic and Peak-of-Dose Dyskinesia

    R. Garcia-Ramos Garcia, A. Fernandez Revuelta, A. Aldaz Burgoa, C. Ribacoba Diaz, A. Alonso Cánovas, I. Parees Moreno, C. Moreno Lopez, JC. Martinez Castrillo (Madrid, Spain)

    Objective: To evaluate the clinical benefit on motor complications of transitioning from levodopa-carbidopa intestinal gel (LCIG) to levodopa-carbidopa-entacapone intestinal gel (LECIG) in a cohort of…
  • 2026 International Congress

    DBS withdrawal syndrome in Parkinson’s disease: Clinical features and outcomes of two new cases

    E. Ottela, J. Rönkä, V. Kaasinen, J. Joutsa (Turku, Finland)

    Objective: To report two cases of deep brain stimulation (DBS) withdrawal syndrome in Parkinson’s disease (PD), including one without typical risk factors. Background: DBS withdrawal…
  • 2026 International Congress

    Subthalamic Deep Brain Stimulation Produces Consistent Improvements in Sleep Quality and Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-analysis

    M. Schiess, J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: This study aims to determine the effects of subthalamic nucleus deep brain stimulation (STN‑DBS) on sleep quality and daytime sleepiness in Parkinson’s disease (PD).…
  • 2026 International Congress

    Deep brain stimulation improves levodopa-induced dyskinesias beyond medication reduction in Parkinson’s disease

    C. Reyes, C. Martínez, J. Fonseca, F. Castro, A. Calderón, L. Reyes, C. Ramírez (Ciudad de México, Mexico)

    Objective: To determine whether the improvement in levodopa-induced dyskinesias after deep brain stimulation is primarily associated with reduction in dopaminergic medication or with a direct…
  • 2026 International Congress

    Can Prayer Beads Quantify Bradykinesia? An Ultra-Low-Cost Approach to Motor Assessment in Parkinson’s Disease

    N. Raisa, B. Perwirayuda, SB. Rianawati, AC. Pratiwi (Malang, Indonesia)

    Objective: To explore the potential use of portable mechanical counters as a simple approach to quantifying finger movement activity in the evaluation of bradykinesia. Background:…
  • 2026 International Congress

    Paired cerebrospinal fluid and serum analysis of irisin and associated LC3B levels in Parkinson’s disease and atypical Parkinsonism

    S. Witte, C. van Riesen, M. Bähr, F. Maass (Göttingen, Germany)

    Objective: The objective of the study is to investigate potential group differences in irisin and LC3B levels in paired cerebrospinal fluid (CSF) and serum samples…
  • 2026 International Congress

    Genetic Rare Variation in Early-Onset Neurodegenerative Movement Disorders: A Clinicopathologic Study.

    T. Du Toit, L. Wu, O. Serrano, N. Kuznetsov, S. Love, A. King, F. Roncaroli, L. Parkkinen, C. Morris, C. Smith, G. Serrano, T. Beach, S. Gentleman, T. Warner, Z. Jaunmuktane, J. Carr, R. Real, H. Morris (London, United Kingdom)

    Objective: To evaluate rare genetic variants in early-onset movement disorder (MD) cases in relation to neuropathology. Background: Accurate diagnosis of neurodegenerative MDs is complicated by…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley